United States Biotechnology & Medical Research

Track

Quoin Pharmaceuticals Ltd (QNRX)

Track

Not featured in screeners

Featured in screeners

Not featured in screeners

Stock chart

Ticker: QNRX Exchange: NAS

Subscribe to get access to the transaction volume chart and in-chart transaction details

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings

Top insiders

Company data & Insiders

Subscribe to get access to the company description and key fundamental data (market cap, shares outstanding, dividend yield, % of shares held by insiders and more)

Download results Settings

Trades

LANGER DENNIS

1 purchase — total 128,640 USD

Buy 14 Oct 2025

Value US$684,437.23 | Price 38.76 | Shares 79,803

Carter Denise P.

Chief Operating Officer

1 purchase — total 250,000 USD

Buy 23 Dec 2024

Value US$1,210,019.37 | Price 227.87 | Shares 40,671

Myers Michael

Chief Executive Officer

1 purchase — total 250,000 USD

Buy 23 Dec 2024

Value US$250,000.20 | Price 0.45 | Shares 555,556

Dunn Gordon

Chief Financial Officer

1 purchase — total 54,999 USD

Buy 23 Dec 2024

Value US$54,999.45 | Price 0.45 | Shares 122,221

Culverwell Anthony James

1 purchase — total 45,000 USD

Buy 23 Dec 2024

Value US$45,000.00 | Price 0.45 | Shares 100,000

Dunn Gordon

Chief Financial Officer

2 purchases — total 16,200 USD

Buy 10 Sep 2024

Value US$7,100.00 | Price 0.71 | Shares 10,000

Buy 10 Sep 2024

Value US$9,100.00 | Price 0.91 | Shares 10,000

Dunn Gordon

Chief Financial Officer

3 purchases — total 7,005 USD

Buy 9 Sep 2024

Value US$3,200.00 | Price 0.80 | Shares 4,000

Buy 9 Sep 2024

Value US$3,120.00 | Price 0.78 | Shares 4,000

Buy 9 Sep 2024

Value US$684.80 | Price 0.80 | Shares 856

Myers Michael

Chief Executive Officer

3 purchases — total 28,421 USD

Buy 4 Sep 2024

Value US$18,796.31 | Price 0.80 | Shares 23,572

Buy 4 Sep 2024

Value US$6,134.42 | Price 0.75 | Shares 8,200

Buy 4 Sep 2024

Value US$3,490.17 | Price 0.66 | Shares 5,322

Carter Denise P.

Chief Operating Officer

2 purchases — total 24,912 USD

Buy 4 Sep 2024

Value US$18,309.94 | Price 0.80 | Shares 22,988

Buy 4 Sep 2024

Value US$6,601.98 | Price 0.75 | Shares 8,825

Myers Michael

Chief Executive Officer

1 purchase — total 495 USD

Buy 3 Sep 2024

Value US$495.20 | Price 0.62 | Shares 800

Carter Denise P.

Chief Operating Officer

2 purchases — total 3,825 USD

Buy 3 Sep 2024

Value US$2,685.91 | Price 0.66 | Shares 4,100

Buy 3 Sep 2024

Value US$1,139.30 | Price 0.63 | Shares 1,822

LANGER DENNIS

2 sales — total 435 USD

Sale 7 Jun 2024

Value US$217.40 | Price 0.73 | Shares 297

Proposed sale 7 Jun 2024

Value US$217.64 | Price 0.73 | Shares 297

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other

Notification date	Transaction date	B/S Transaction type	Insider and/or position	Nb. shares Price Value	Number of shares	Price	Value
2025-10-15	2025-10-14	B Purchase	2.5 LANGER DENNIS Non-Executive Director	79,803 -16.1% 38.76 US$684,437	79,803 -16.1%	38.76	US$684,437
2024-12-27	2024-12-23	B Purchase	1.6 Carter Denise P. Chief Operating Officer Executive Director	40,671 +43.1% 227.87 US$1,210,019	40,671 +43.1%	227.87	US$1,210,019
2024-12-27	2024-12-23	B Purchase	1.8 Myers Michael Chief Executive Officer Executive Director	9,673 +43.0% 394.45 US$4,456,064	9,673 +43.0%	394.45	US$4,456,064
2024-12-27	2024-12-23	B Purchase	1.2 Dunn Gordon Chief Financial Officer Officer	122,221 +423.6% 0.45 US$54,999	122,221 +423.6%	0.45	US$54,999
2024-12-27	2024-12-23	B Purchase	Culverwell Anthony James Non-Executive Director	100,000 +31545.7% 0.45 US$45,000	100,000 +31545.7%	0.45	US$45,000
2024-09-11	2024-09-10	B Purchase	1.2 Dunn Gordon Chief Financial Officer Officer	10,000 +53.0% 0.71 US$7,100	10,000 +53.0%	0.71	US$7,100
2024-09-11	2024-09-10	B Purchase	1.2 Dunn Gordon Chief Financial Officer Officer	10,000 +112.9% 0.91 US$9,100	10,000 +112.9%	0.91	US$9,100
2024-09-11	2024-09-09	B Purchase	1.2 Dunn Gordon Chief Financial Officer Officer	4,000 +82.4% 0.80 US$3,200	4,000 +82.4%	0.80	US$3,200
2024-09-11	2024-09-09	B Purchase	1.2 Dunn Gordon Chief Financial Officer Officer	4,000 +467.3% 0.78 US$3,120	4,000 +467.3%	0.78	US$3,120
2024-09-11	2024-09-09	B Purchase	1.2 Dunn Gordon Chief Financial Officer Officer	856 +inf% 0.80 US$685	856 +inf%	0.80	US$685
2024-09-05	2024-09-04	B Purchase	1.8 Myers Michael Chief Executive Officer Executive Director	23,572 +99.5% 0.80 US$18,796	23,572 +99.5%	0.80	US$18,796
2024-09-05	2024-09-04	B Purchase	1.8 Myers Michael Chief Executive Officer Executive Director	8,200 +53.0% 0.75 US$6,134	8,200 +53.0%	0.75	US$6,134
2024-09-05	2024-09-04	B Purchase	1.8 Myers Michael Chief Executive Officer Executive Director	5,322 +52.4% 0.66 US$3,490	5,322 +52.4%	0.66	US$3,490
2024-09-05	2024-09-04	B Purchase	1.6 Carter Denise P. Chief Operating Officer Executive Director	22,988 +95.4% 0.80 US$18,310	22,988 +95.4%	0.80	US$18,310
2024-09-05	2024-09-04	B Purchase	1.6 Carter Denise P. Chief Operating Officer Executive Director	8,825 +57.8% 0.75 US$6,602	8,825 +57.8%	0.75	US$6,602
2024-09-05	2024-09-03	B Purchase	1.8 Myers Michael Chief Executive Officer Executive Director	800 +8.5% 0.62 US$495	800 +8.5%	0.62	US$495
2024-09-05	2024-09-03	B Purchase	1.6 Carter Denise P. Chief Operating Officer Executive Director	4,100 +36.7% 0.66 US$2,686	4,100 +36.7%	0.66	US$2,686
2024-09-05	2024-09-03	B Purchase	1.6 Carter Denise P. Chief Operating Officer Executive Director	1,822 +19.5% 0.63 US$1,139	1,822 +19.5%	0.63	US$1,139
2024-06-10	2024-06-07	S Sale	2.5 LANGER DENNIS Non-Executive Director	297 -84.9% 0.73 US$217	297 -84.9%	0.73	US$217
2024-06-07	2024-06-07	PrS Proposed sale	2.5 LANGER DENNIS Director Non-Executive Director	297 0.73 US$218	297	0.73	US$218